large

Hettich India recognised among the Top 50 India’s Best Workplaces in Manufacturing 2026 – Large Category

MUMBAI, India, Feb. 2, 2026 /PRNewswire/ -- Hettich India has been recognised among the Top 50 India's Best Workplaces™ in…

5 days ago

BIO-key and Visualforma Awarded Contract to Secure Digital Identities for Large Municipality in Portugal

HOLMDEL, N.J. and FARO, Portugal, Jan. 28, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a leading provider of…

1 week ago

Strong Q3 Performance: Sequential Revenue Growth of 0.6% in CC, Large Deal Wins of $4.8 billion

Revenue Guidance for FY 26 revised to 3.0%-3.5%BENGALURU, India, Jan. 14, 2026 /PRNewswire/ -- Infosys (NSE: INFY), (BSE: INFY), (NYSE: INFY),…

3 weeks ago

Online Casino Real Money No Deposit Bonus Get $5 No Deposit Bonus + Large Welcome Bonus By BC Poker

New York City, NY, Dec. 27, 2025 (GLOBE NEWSWIRE) --  Players searching for an online casino real money no deposit…

1 month ago

Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition

93% overall response and 76% complete response rates with median progression-free survival of 18 months in patients with large B-cell…

2 months ago

Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption

July 29, 2025 09:01 ET  | Source: Windtree Therapeutics Investors choose to redeem or convert the majority of Series C…

6 months ago

Genmab Announces Epcoritamab Investigational Combination Therapy Demonstrates High Response Rates in Patients with Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) Eligible for Autologous Stem Cell Transplantation (ASCT)

Media ReleaseCOPENHAGEN, Denmark; June 15, 2025 Results from the EPCORE® NHL-2 trial show investigational treatment with epcoritamab in combination with…

8 months ago